|
Somnogen is a Canadian multinational pharmaceutical corporation with its global headquarters located in Toronto, Canada. Somnogen produces and develop a wide range of prescription and over-the-counter medications in the field of sleep medicine. Somnogen has a portfolio of products for major areas within the field of sleep/wake therapeutic segment including, insomnia and excessive daytime sleepiness. Somogen was founded by Seithikurippu Ratnas Pandi-Perumal, who was an Indian-born Canadian citizen. Somnogen initially launched its operation in India with a set of prescription and over-the-counter portfolio sleep medications. Currently the companay doesn't have a factory of its own, but contract manufacture its products with other contract manufacturing companies. ==Product portfolio== Achoosom tablets (Diphenhydramine HCl 10 mg) Benzax 0.25/0.5 mg tablets (Alprazolam 0.25 mg and 0.5 mg) Benzax-F tablets (Alprazolam 0.25 mg + Fluoxetine 20 mg) Depresom-ID tablets (Imipramine HCl 25 mg + Diazepam 5 mg) Doxesom tablets (Doxepin HCl 3 mg) Hydrozet-10 tablets (Cetirizine HCl 10 mg) Loresta tablets (Lorazepam 1 mg and 2 mg) Somnotril 0.5 tablets (Clonazepam 0.5 mg) Somnolex tablets (Clonazepam 0.5 mg + Ecitalopram 10 mg) Tophan capsules (Tryptophan 50 mg) Xanfeine tablets (Caffeine 100 mg) Zoltar 5/10 tablets (Zolpidem tartrate 5 mg and 10 mg) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Somnogen Canada Inc」の詳細全文を読む スポンサード リンク
|